F. Ranchon, G. Salles, H. Spath, V. Schwiertz, N. Vantard et al., Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs, BMC Cancer, vol.23, issue.1, p.478, 2011.
DOI : 10.1023/A:1011252132478

A. Fyhr and R. Akselsson, Characteristics of medication errors with parenteral cytotoxic drugs, European Journal of Cancer Care, vol.21, issue.5, pp.606-619, 2012.
DOI : 10.1111/j.1365-2354.2012.01331.x

E. Schmitt, D. Antier, C. Bernheim, E. Dufay, M. Husson et al., Dictionnaire Français de l'erreur médicamenteuse. Société Française de Pharmacie Clinique, 2006.

R. Kaushal, K. Shojania, and D. Bates, Effects of Computerized Physician Order Entry and Clinical Decision Support Systems on Medication Safety, Archives of Internal Medicine, vol.163, issue.12, pp.1409-1425, 2003.
DOI : 10.1001/archinte.163.12.1409

J. Bubalo, B. Warden, J. Wiegel, T. Nishida, E. Handel et al., Does applying technology throughout the medication use process improve patient safety with antineoplastics?, Journal of Oncology Pharmacy Practice, vol.320, issue.7237, pp.445-60, 2014.
DOI : 10.1177/1078155213514469

B. Gruwez, J. Penaud, V. Lecante, I. Lopez, and A. Dauphin, Exemple d'analyse de processus de fabrication en pharmacotechnie hospitalière, J Pharm Clin, vol.20, issue.3, pp.145-153, 2001.

T. Connor, D. Debord, B. Mackenzie, O. Callaghan, J. Trout et al., NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2014. US Department of Health and Human Services, National Institute for Occupational Safety and Health, 2014.

J. Phillips, S. Beam, A. Brinker, C. Holquist, P. Honig et al., Retrospective analysis of mortalities associated with medication errors, Am J Health Syst Pharm, vol.58, pp.1835-1876, 2001.

A. Markert, V. Thierry, M. Kleber, M. Behrens, and M. Engelhardt, Chemotherapy safety and severe adverse events in cancer patients: Strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment, International Journal of Cancer, vol.285, issue.3, pp.722-730, 2009.
DOI : 10.1002/ijc.23991

T. Gandhi, S. Bartel, L. Shulman, D. Verrier, E. Burdick et al., Medication safety in the ambulatory chemotherapy setting, Cancer, vol.14, issue.11, pp.2477-83, 2005.
DOI : 10.1002/cncr.21442

E. Flynn, R. Pearson, and K. Barker, Observational study of accuracy in compounding i.v. admixtures at five hospitals, Am J Health Syst Pharm, vol.54, issue.8, pp.904-916, 1997.

C. Parshuram, T. To, W. Seto, A. Trope, G. Koren et al., Systematic evaluation of errors occurring during the preparation of intravenous medication, Canadian Medical Association Journal, vol.178, issue.1, pp.42-50, 2008.
DOI : 10.1503/cmaj.061743

L. Sarfati, F. Ranchon, N. Vantard, V. Schwiertz, N. Gauthier et al., SIMMEON-Prep study: SIMulation of Medication Errors in ONcology: prevention of antineoplastic preparation errors, Journal of Clinical Pharmacy and Therapeutics, vol.21, issue.1, pp.55-62, 2015.
DOI : 10.1111/jcpt.12225

S. Watt, D. Antier, V. Jacques, and J. Grassin, Validation et mise en place d'un nouveau programme de contrôle-qualité des cytotoxiques reconstitués en unité centralisée, J Pharm Clin, vol.21, issue.3, pp.179-82, 2002.

I. Borget, I. Laville, A. Paci, S. Michiels, L. Mercier et al., Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacy, European Journal of Pharmaceutics and Biopharmaceutics, vol.64, issue.1, pp.92-100, 2006.
DOI : 10.1016/j.ejpb.2006.04.002

A. Delmas, J. Gordien, J. Bernadou, M. Roudaut, A. Gresser et al., Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in a centralized parenteral preparations unit, Journal of Pharmaceutical and Biomedical Analysis, vol.49, issue.5, pp.1213-1233, 2009.
DOI : 10.1016/j.jpba.2009.03.007

T. Chouquet, K. Morand, and G. Benoît, Mise en place du contrôle analytique des préparations de chimiothérapies injectables de faible volume, Congrès GERPAC, vol.2014

B. Bonan, N. Martelli, M. Berhoune, M. Maestroni, L. Havard et al., The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs, International Journal for Quality in Health Care, vol.21, issue.1, pp.44-50, 2009.
DOI : 10.1093/intqhc/mzn052

M. Ponseele, N. Nicolas, C. Clémence, and M. Mougeot, Élaboration du plan de gestion des risques de la préparation des cytotoxiques à l

R. White, A. Cassano-piche, A. Fields, R. Cheng, and A. Easty, Intravenous chemotherapy preparation errors: Patient safety risks identified in a pan-Canadian exploratory study, Journal of Oncology Pharmacy Practice, vol.320, issue.1, pp.40-46, 2014.
DOI : 10.1056/NEJM199102073240605

R. Bateman and P. Donyai, Errors associated with the preparation of aseptic products in UK hospital pharmacies: lessons from the national aseptic error reporting scheme, BMJ Quality & Safety, vol.19, issue.5, 2010.
DOI : 10.1136/qshc.2009.034751

D. Kohler, M. Montello, B. Goldspiel, R. Dechristoforo, C. Huntley et al., ASHP Guidelines on Preventing Medication Errors with Antineoplasic Agents, Am J Health- Syst Pharm, vol.59, pp.1648-68, 2002.

C. Legat, S. Limat, J. Coutet, D. , F. Jacquet et al., Impact économique de la préparation centralisée des médicaments anticancéreux, J Pharm Clin, vol.22, issue.4, pp.181-186, 2003.

G. Leboucher, F. Serratrice, V. Bertholle, L. Thore, and M. Bost, Evaluation de la contamination par le platine d'une unité centralisée de préparation des médicaments cytotoxiques, Bull Cancer, vol.89, issue.11, pp.949-55, 2002.

F. Augry, P. Ravaud, I. Lopez, D. Letellier, A. Iltis et al., Erreurs de prescription des médicaments cytotoxiques : étude prospective de 5 000 ordonnances, J Pharm Clin, vol.17, issue.1, pp.20-24, 1998.

B. Meisenberg, R. Wright, and C. Brady-copertino, Reduction in Chemotherapy Order Errors With Computerized Physician Order Entry, Journal of Oncology Practice, vol.10, issue.1, pp.5-9, 2014.
DOI : 10.1200/JOP.2013.000903

L. Carrez, Fiabilité de la préparation des chimiothérapies : double contrôle ou systèmes gravimétriques Eléments de réponse par une étude de simulation [Thèse d'exercice: Pharmacie], 2013.

H. Seibert, R. Maddox, E. Flynn, and C. Williams, Effect of barcode technology with electronic medication administration record on medication accuracy rates, American Journal of Health-System Pharmacy, vol.71, issue.3, pp.209-227, 2014.
DOI : 10.2146/ajhp130332

K. Marx, L. Stoudenmire, and B. M. Kalen, Publication of pediatric and neonatal articles in the pharmacy literature from 2000 to 2010, American Journal of Health-System Pharmacy, vol.70, issue.7, pp.571-573, 2000.
DOI : 10.2146/ajhp120312

P. Bonnabry, L. Cingria, M. Ackermann, F. Sadeghipour, L. Bigler et al., Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process, International Journal for Quality in Health Care, vol.18, issue.1, pp.9-16, 2006.
DOI : 10.1093/intqhc/mzi082

E. Pelus, M. Dellanegra, D. Charlety, N. Magnin, N. Petit et al., Unité de préparation centralisée des cytotoxiques : de la mise en place à l'assurance-qualité, J Pharm Clin, vol.17, issue.2, pp.97-102, 1998.

J. Descout, C. Grignon, S. Coulon, and A. Dauphin, Analyse des différentes méthodes de contrôle des chimiothérapies anticancéreuses de 30 hôpitaux français, Congrès GERPAC (Presqu'île de Giens, 2011.

N. Facchinetti, G. Campbell, and D. Jones, Evaluating Dispensing Error Detection Rates in a Hospital Pharmacy, Medical Care, vol.37, issue.1, pp.39-43, 1999.
DOI : 10.1097/00005650-199901000-00007

D. Dawson and K. Reid, Fatigue, alcohol and performance impairment, Nature, vol.388, issue.6639, pp.235-235, 1997.
DOI : 10.1038/40775

D. Gaba and S. Howard, Fatigue among Clinicians and the Safety of Patients, New England Journal of Medicine, vol.347, issue.16, pp.1249-55, 2002.
DOI : 10.1056/NEJMsa020846

M. Stefl, To Err is Human: Building a Safer Health System in 1999, Front Health Serv Manage, vol.18, issue.1, pp.1-2, 2001.

J. Lecordier, Y. Heluin, C. Plivard, A. Bureau, C. Mouawad et al., Safety in the preparation of cytotoxic drugs: How to integrate gravimetric control in the quality assurance policy?, Biomedicine & Pharmacotherapy, vol.65, issue.1, pp.17-21, 2011.
DOI : 10.1016/j.biopha.2010.12.014

D. Lebel, M. Thibault, and J. Bussières, Asynchronous Validation and Documentation of Sterile Compounding in a Hospital Pharmacy, The Canadian Journal of Hospital Pharmacy, vol.63, issue.4, pp.323-330, 2010.
DOI : 10.4212/cjhp.v63i4.937

D. Lebel, M. Ponton, M. Racine, and J. Bussières, Application pratique de la télépharmacie pour les préparations stériles de médicaments, Pharmactuel, vol.41, issue.1, pp.44-51, 2008.

O. Neal, B. Worden, J. Couldry, and R. , Telepharmacy and bar-code technology in an i.v. chemotherapy admixture area, American Journal of Health-System Pharmacy, vol.66, issue.13, pp.1211-1218, 2009.
DOI : 10.2146/ajhp080388

T. Moniz, S. Chu, C. Tom, P. Lutz, A. Arnold et al., Sterile product compounding using an i.v. compounding workflow management system at a pediatric hospital, American Journal of Health-System Pharmacy, vol.71, issue.15, pp.1311-1318, 2014.
DOI : 10.2146/ajhp130649

L. Caméras-prennent-le-relai, Le moniteur HOSPITALIER n°207, 2008.

L. Franc, B. Chauvet, P. Griesemann, E. Cante, and J. , Evaluation de la faisabilité d'un contrôle libératoire des préparations de cytotoxiques par capture vidéo, Congrès GERPAC

L. Franc, B. Dalifard, B. Griesemann, E. Cante, and J. , L'enregistrement vidéo pour le contrôle de qualité des préparations de cytotoxiques. Congrès: GERPAC; Presqu'île de Giens, 2010.

B. Dalifard, M. Dermu, L. Franc, B. Griesemann, E. Cante et al., Reconnaissance des flacons d'Erbitux®, de Cisplatine et de Navelbine® par analyse vidéo : Validation en conditions réelles de l'identification des flacons, Congrès: GERPAC, 2012.

A. Chourbagi, E. Delbary, B. Dalifard, L. Franc, B. Cante et al., Reconnaissance des flacons de cytotoxiques par analyse vidéo : validation en conditions réelles. Congrès: Hopipharm; Reims, 2015.

C. Tron, A. Bedoucha, B. Dalifard, L. Franc, B. Cante et al., Validation de la détection des volumes de seringues par vidéocapture: application à la seringue de 10 mL. Congrès: Hopipharm; Lyon, 2013.

M. Vaubourdolle and . Toxicologie, sciences mathématiques, physiques et chimiques, Malmaison: Éd. Wolters Kluwer, 2007.

A. Vogel, J. Mendham, J. Toullec, and M. Mottet, Analyse chimique quantitative de Vogel, 2006.

P. Bourget, A. Paci, J. Rey, L. Mercier, and S. Demirdjian, Contribution of high-performance thin-layer chromatography to a pharmaceutical quality assurance programme in a hospital chemotherapy manufacturing unit, European Journal of Pharmaceutics and Biopharmaceutics, vol.56, issue.3, pp.445-51, 2003.
DOI : 10.1016/S0939-6411(03)00117-6

E. Gravel, P. Bourget, L. Mercier, and A. Paci, Fluorescence detection combined with either HPLC or HPTLC for pharmaceutical quality control in a hospital chemotherapy production unit: Application to camptothecin derivatives, Journal of Pharmaceutical and Biomedical Analysis, vol.39, issue.3-4, pp.3-4581, 2005.
DOI : 10.1016/j.jpba.2005.05.010

J. Bouligand, A. Paci, L. Mercier, G. Vassal, and P. Bourget, High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical products, Journal of Pharmaceutical and Biomedical Analysis, vol.34, issue.3, pp.525-555, 2004.
DOI : 10.1016/S0731-7085(03)00630-7

A. Paci, L. Mercier, and P. Bourget, Identification and quantitation of antineoplastic compounds in chemotherapeutic infusion bags by use of HPTLC: application to the vinca-alkaloids, Journal of Pharmaceutical and Biomedical Analysis, vol.30, issue.5, pp.1603-1613, 2003.
DOI : 10.1016/S0731-7085(02)00541-1

J. Bouligand, T. Storme, I. Laville, L. Mercier, O. Oberlin et al., Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products, Journal of Pharmaceutical and Biomedical Analysis, vol.38, issue.1, pp.180-185, 2005.
DOI : 10.1016/j.jpba.2004.12.001

A. Paci, I. Borget, L. Mercier, Y. Azar, R. Desmaris et al., Safety and quality assurance of chemotherapeutic preparations in a hospital production unit: Acceptance sampling plan and economic impact, Journal of Oncology Pharmacy Practice, vol.09, issue.2, pp.163-70, 2012.
DOI : 10.1177/1078155211402865

S. Blain, Analyse par injection en flux continu (FIA) http://www.techniquesingenieur.fr/base-documentaire/mesures-analyses-th1/chromatographie-et-techniques- separatives-42385210/analyse-par-injection-en-flux-continu-fia-p1510, 2006.

L. Havard, B. Bonan, J. Huen, Y. Roche, and P. Prognon, Le contrôle de qualité en unité centralisée de reconstitution des cytotoxiques : mythe ou réalité? STP Pharma Prat, pp.148-60, 2005.

F. Basuyau and P. Brunelle, Comparaison de deux mesures physiques rapides pour le contrôle de la dose des préparations injectables de médicaments anticancéreux avant administration : application au 5-fluorouracile, J Pharm Clin, vol.19, issue.1, pp.5-9, 2000.

M. Kuzzay, M. A. Antier, and D. , Avantages et limites d'une analyse IRTF-UV. Congrès: GERPAC; Presqu'île de Giens, 2009.

F. Dziopa, G. Galy, S. Bauler, B. Vincent, S. Crochon et al., A quantitative and qualitative method to control chemotherapeutic preparations by Fourier transform infrared???ultraviolet spectrophotometry, Journal of Oncology Pharmacy Practice, vol.98, issue.2, pp.121-130, 2013.
DOI : 10.1177/1078155212457963

C. Bazin, V. Vieillard, A. Astier, and M. Paul, Contr??le rapide et fiable des pr??parations de chimioth??rapies ?? base d???anticorps monoclonaux ?? l???aide de l???automate Multispec??, Annales Pharmaceutiques Fran??aises, vol.68, issue.3, pp.163-77, 2010.
DOI : 10.1016/j.pharma.2010.03.008

B. Cassard, P. Bourget, C. Rozenn, and P. Prognon, La Spectroscopie Raman, une solution ultrarapide et non destructrice pour le Contrôle de Qualité Analytique des solutions injectables ; application aux oxazaphosphorines, Congrès, 2009.

P. Bourget, A. Amin, A. Moriceau, B. Cassard, F. Vidal et al., La Spectroscopie Raman (SR)??: un nouvel outil adapt?? au contr??le de qualit?? analytique des pr??parations injectables en milieu de soins. Comparaison de la SR aux techniques CLHP et UV/visible-IRTF??appliqu??e ?? la classe des anthracyclines en canc??rologie, Pathologie Biologie, vol.60, issue.6, pp.369-79, 2012.
DOI : 10.1016/j.patbio.2011.10.010

B. Barin, N. Fayad, S. Rochard, and P. Baumgartner, Spectre RAMAN : premier pas vers une méthode simple (sans échantillon, sans destruction) de contrôle des préparations d'anticancéreux ? Congrès: GERPAC; Presqu'île de Giens, 2010.

P. Bourget, A. Amin, F. Vidal, C. Merlette, and F. Lagarce, Comparison of Raman spectroscopy vs. high performance liquid chromatography for quality control of complex therapeutic objects: Model of elastomeric portable pumps filled with a fluorouracil solution, Journal of Pharmaceutical and Biomedical Analysis, vol.91, pp.176-84, 2014.
DOI : 10.1016/j.jpba.2013.12.030

S. Hé, Le contrôle des préparations d'anticancéreux, pp.19-29, 2013.

P. Bourget, A. Amin, F. Vidal, C. Merlette, P. Troude et al., The contribution of Raman spectroscopy to the analytical quality control of cytotoxic drugs in a hospital environment: Eliminating the exposure risks for staff members and their work environment, International Journal of Pharmaceutics, vol.470, issue.1-2, pp.70-76, 2014.
DOI : 10.1016/j.ijpharm.2014.04.064

S. Gouvernement-du-canada, Q2A: Texte concernant la validation des méthodes d'analyse [Internet], 1999.

B. Dalifard, M. Laplace, C. Blancher, L. Franc, B. Cadeac et al., Sécuriser la préparation des chimiothérapies anticancéreuses injectables : quel bilan après la fabrication de 2140 préparations vidéo-contrôlées ? Congrès Hopipharm; Reims, 2015.